Cohort | Single-dose study (once) | Multiple-dose study (twice daily for 14 days) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |
Increase,% | Starting dose | 200 | 100 | 100 | 67 | 60 | 50 | 33 | – | – | – |
Dosea | 90 | 270 | 540 | 1080 | 1800 | 2880 | 4320 | 5760 | 360 | 720 | 2160 |
Men | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
Women | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
Group allocation | |||||||||||
 Active ingredients | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | 6 | 6 | 6 |
 Placebo | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
 Total | 6 | 8 | 8 | 8 | 8 | 8 | 8 | 6 | 8 | 8 | 8 |